18 and older, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Number of Study Participants Who Have Completed a Palliative Care Visit Within 3 Months of EnrollmentPrimary· 3 months
Completed palliative care visit within 3 months among high-risk patients with stage III and IV lung and non-colorectal GI malignancies
Group
Value
95% CI
Control
22
Intervention
130
Sponsor's own description
Patients with advanced cancer suffer from high symptom burden and aggressive end-of-life care. Early specialty palliative care is an evidence-based practice that improves symptom burden, quality of life, and survival in advanced cancer. However, over half of patients with advanced cancer die before receiving palliative care. Clinician-level biases and suboptimal identification of high-risk patients are major barriers to palliative care uptake. In this 2-arm pragmatic clinical trial, the investigators will randomize practices within a large community oncology network to receive an intervention consisting of algorithm-based default palliative care referrals. The investigators will study the impact of such an intervention on palliative care utilization and end-of-life outcomes.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors
· NA
· recruiting
NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy
· NA
· recruiting
NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients.
· NA
· recruiting
NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations
· NA
· recruiting
NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety
· NA
· recruiting
Other Abramson Cancer Center at Penn Medicine trials
Trials by the same sponsor.
NCT07478848 — Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas
· Phase 1
· not yet recruiting
NCT07059611 — Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma
· Phase 2
· not yet recruiting
NCT07454499 — Engaging M-health for Symptom Monitoring and Health Promotion for Women on Endocrine Therapy for Breast Cancer (EmSHAPE)
· NA
· not yet recruiting
NCT07222241 — Comparing Numbing Techniques in Mohs Micrographic Surgery
· NA
· recruiting
NCT06837480 — Photobiomodulation in Head and Neck Cancer-Related Chronic Lymphedema
· NA
· recruiting
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Abramson Cancer Center at Penn Medicine
Last refreshed: 6 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05590962.